Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Seagen Inc.
PMV Pharmaceuticals, Inc
Hoffmann-La Roche
Tizona Therapeutics, Inc
UNC Lineberger Comprehensive Cancer Center
Novartis
Inhibrx Biosciences, Inc
VM Oncology, LLC
Astellas Pharma Inc
MacroGenics
Incyte Corporation
National Institutes of Health Clinical Center (CC)
DEKA Biosciences
Rapa Therapeutics LLC
Intensity Therapeutics, Inc.
Carisma Therapeutics Inc
NextCure, Inc.
Inhibrx Biosciences, Inc
iTeos Therapeutics
Rutgers, The State University of New Jersey
Celldex Therapeutics
Ikena Oncology
University Hospital, Ghent
Fate Therapeutics
Kineta Inc.
Seagen Inc.
Fate Therapeutics
Silverback Therapeutics
Incyte Corporation
Incyte Corporation